Mark S Cragg

45PUBLICATIONS
189CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsAutoimmunityTumour immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Aug 23, 2026
ACE2 decoy Fc-fusions and bispecific killer engagers require Fc engagement for in vivo efficacy against SARS-CoV-2.

|Jul 17, 2026
Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Employ Distinct Modes of Action to Induce Antitumor Immunity.

|Jun 29, 2026
Gas-phase unfolding assay rapidly predicts structure-function relationships in engineered antibodies with tuned flexibilities.

|May 19, 2026
Realizing the potential of agonistic antibody immunotherapy.

|Apr 17, 2026
The autoantigen TRIM21 assembles proinflammatory immune complexes after lytic cell death.

|Jan 13, 2026
CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A.

Lara V Graham, Russell B Foxall, Margaret Ashton-Key

Pageof 8

Frequent Collaborators

8 joint publications

Stephen A Beers

7 joint publications

Sean H Lim

5 joint publications

Robert J Oldham

4 joint publications

Francesco Forconi